Cargando…
CCL1 is a major regulatory T cell attracting factor in human breast cancer
BACKGROUND: Regulatory T cells (Treg) suppress cytotoxic T cell anti-tumoral immune responses and thereby promote tumor progression. Prevention of intratumoral Treg accumulation by inhibition of their migration to the tumor microenvironment is a promising therapeutic strategy. The aim of this study...
Autores principales: | Kuehnemuth, Benjamin, Piseddu, Ignazio, Wiedemann, Gabriela M., Lauseker, Michael, Kuhn, Christina, Hofmann, Simone, Schmoeckel, Elisa, Endres, Stefan, Mayr, Doris, Jeschke, Udo, Anz, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302432/ https://www.ncbi.nlm.nih.gov/pubmed/30572845 http://dx.doi.org/10.1186/s12885-018-5117-8 |
Ejemplares similares
-
Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018) -
Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017) -
Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients
por: Wang, Qun, et al.
Publicado: (2019) -
Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2
por: Meister, Sarah, et al.
Publicado: (2022) -
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes
por: Rapp, Moritz, et al.
Publicado: (2019)